You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: faecal occult blood test screening reduces risk of colorectal cancer mortality

https://doi.org/10.1136/ebm.14.1.15

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    P Hewitson

    Dr P Hewitson, University of Oxford, Headington, UK; paul.hewitson@dphpc.ox.ac.uk

    QUESTION

    Does faecal occult blood test (FOBT) screening reduce colorectal cancer mortality?

    REVIEW SCOPE

    Included studies evaluated annual or biennial screening for colorectal cancer with guaiac or immunochemical FOBTs. Outcomes included incidence of colorectal cancer, colorectal cancer mortality, and all-cause mortality.

    REVIEW METHODS

    Medline, CINAHL, EMBASE/Excerpta Medica, Cochrane Library (Issue 1, 2005), PsycINFO, Allied and Complementary Medicine Database, System of Information on Grey Literature in Europe, Healthcare Management Information Consortium, and reference lists were searched from 1989 to February 2006 for randomised controlled trials (RCTs). 4 RCTs (n = 329 642, age 45–80 y) …

    View Full Text

    Footnotes

    • Source of funding: Cancer Research UK.